表紙:自閉症治療センターの米国市場
市場調査レポート
商品コード
1123364

自閉症治療センターの米国市場

The U.S. Autism Treatment Centers Market

出版日: | 発行: Marketdata LLC | ページ情報: 英文 106 Pages; 15 Competitor Profiles | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
自閉症治療センターの米国市場
出版日: 2022年09月06日
発行: Marketdata LLC
ページ情報: 英文 106 Pages; 15 Competitor Profiles
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

米国の子供たちの自閉症の発症率は、2000年の150人に1人から、現在では44人に1人と急増し、680万人の子供や成人が自閉症を患っています。しかし、この病気に対する治療法はほとんどなく、わずかな投薬治療とABA(応用行動分析)プログラムしかありません。

当レポートでは、営利/非営利のプロバイダーで構成され、自閉症患者のための施設やセラピストによる在宅セラピーを提供する、40億米ドル超の断片的な米国の成長市場について検証しています。

目次

イントロダクション:調査範囲・調査手法

主な調査結果の概要

  • 全章のハイライト:市場の性質と特徴、主要な市場指標、患者の人口統計と需要、市場構造と競合、ABAプログラムの説明、市場規模と成長率(2009年~2019年、2020年~パンデミックの影響、2021年の実績、2022年・2025年の見通しと予測)、プライベートエクイティ投資家の役割

ABA治療センターとプログラム(応用行動分析)

  • 概要 - プログラムのタイプに関する考察:センターベース、コミュニティ、在宅療法
  • 主要な指標(自閉症の成人と子供の数、治療センターあたりの平均収益、セラピストあたりの平均、薬剤使用の患者の割合、保険適用加入の割合、推定の市場金額)
  • ABAプログラムの仕組み、治療のタイプ、論争についての詳細な説明
  • その他の治療法(TEAACH、言語療法、作業療法)についての説明
  • 保険適用に関する障害、メディケア、メディケイド、その他の主要な市場問題、保険適用の改善、必須の医療給付の無い州、現在 vs. 2016年の保険適用の子供の割合
  • 2029年までの応用行動分析士のBLSによる仕事の見通し、平均給与、不足
  • ライセンス行動分析士の需要 - 過去12年間の全国の年間求人数(2010年~2021年)
  • 応用行動分析士の給与レベル:高給の州、時給/年収
  • 保険制度は改善されつつある:考察
  • ケア/ABAプログラムのコスト - ニーズとタイプによって異なる、典型的な時間数と年間コスト

市場規模・成長率、市場セグメント

  • 概要:市場規模の推定方法、自閉症治療市場の既知の事実、主要な産業指標についての考察
  • 市場の主要促進要因についての考察

非営利/営利の自閉症治療センター・学校の分析:

  • 非営利/営利の自閉症治療センター・学校の分析
  • 2020年の市場実績:2020年パンデミックの影響、業界規模・成長率の推定、データベース内の非営利治療センター137の収益実績(新しい分析)
  • 2021年の市場実績:パンデミックからの回復、一部バーチャル運用への移行
  • 2022年の市場予測:新センターの追加、大手営利企業による買収
  • 2025年の予測:需要に影響を与える主な要因、業界規模・成長率の推定
  • 市場規模推定の根拠
  • 入手可能な情報・代理指標に関する考察
  • 保険適用に関する考察
  • 成長要因

自閉症治療薬市場の分析

  • 売上縮小の理由、市場規模に関する考察

自閉症治療薬の市場

  • 精神安定剤、抗精神病薬、興奮剤など、自閉症児の行動や情緒問題の治療に現在使用されている薬剤の概要と考察

研究・臨床試験を行っている製薬会社のリスト

  • リスパダール:説明と使用法、副作用と問題点
  • エビリファイ:説明と使用法、副作用と問題点
  • リタリン:説明と使用法、副作用と問題点
  • 市場規模:推定、製薬会社による実際の売上、特許切れによる安価なジェネリック医薬品の出現
  • 開発中の新薬(ブメタニド、バロバプタン、スラミン、リトビド、その他)

自閉症治療薬市場の主要企業のリスト

  • 2022年の予測:市場規模の推定
  • 2025年の予測:市場規模の推定

競合企業プロファイル

  • Autism Treatment Network (Autism Speaks)
  • Autism Learning Partners
  • Autism Spectrum Therapies
  • Butterfly Effects
  • BlueSprig
  • Centria Autism Services
  • The Center for Autism & Related Disorders (CARD)
  • ChanceLight (TM) Behavioral Health and Education
  • City Pro Group
  • Easter Seals
  • Hi-5 ABA Inc. (franchise)
  • Hopebridge
  • Kadiant
  • LEARN Behavioral
  • The May Institute - (incl. 2018-2021 financial profile/income statement)
  • Success on the Spectrum (franchise)
  • Trumpet Behavioral Health

リファレンスディレクトリ

目次

This Marketdata study examines the fragmented $4+ billion U.S. growth market comprised of for-profit and non-profit providers that serve autistic patients via brick & mortar centers and in-home therapy provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging.

The incidence of autism among American children has soared from 1 in 150 in 2000 to 1 in 44 today, and 6.8 million children and adults now live with autism. Yet, few therapies exist to treat this disease-just a few medications and ABA (applied behavioral analysis) programs.

This groundbreaking report includes: dollar value & growth of the market from 2009 to 2019, 2020, 2021 performance, 2022 and 2025 forecasts, market structure, key metrics of treatment centers, definition of and the types of autism, typical therapies used, how ABA programs work and key metrics, insurance coverage, patient demographics, analysis of the market for drugs to treat autism (Risperdal, new drugs in development), the latest CDC research and demographics on autism, market growth factors, economic costs, the effects of the Covid-19 pandemic on operations, analysis of for-profit vs. non-profit treatment centers, discussion of the role of private equity and recent deals, plus a ranking of the top for-profit treatment center chains and their revenues.

Includes a first-ever, comprehensive analysis by Marketdata of the 2018-2020 revenues of non-profit treatment centers/schools and how well they fared during the pandemic in 2020, based on IRS data in the Guidestar.org non-profit database.

Contains 14 in-depth competitor profiles and revenues of the largest players in the field: Autism Speaks, Centria Autism Services, The Center for Autism & Related Disorders, the May Institute, Butterfly Effects, Autism Learning Partners, Autism Spectrum Therapies, Chance Light Behavioral Health, Hopebridge, Trumpet Behavioral Health, Easter Seals, LEARN Behavioral, BlueSprig, Kadiant, and Success on the Spectrum, Hi-5 ABA.

Table of Contents

Introduction: Study Scope & Methodology

Executive Overview of Major Findings

  • Highlights of all report chapters: Nature of the market and its characteristics, key market metrics, patient demographics and demand, market structure and competition, description of ABA programs, market size and growth (2009-2019, 2020 - effects of the pandemic,2021 performance, 2022 & 2025 outlook & forecasts), the role of private equity investors.

Tables

  • The Major For-profit Autism Treatment Center Chains: 2021 (no. of centers)
  • Number of Autistic Children in the U.S. by Type: 2020
  • Estimated Size of the U.S. Autism Treatment Market: 2009-2025 Forecast
  • Summary: Definition of Autism Spectrum Disorder, typical symptoms, incidence
    • In the population
    • Types of treatments used
    • Non-profit vs. for-profit treatment centers
    • Patient demographics: Latest CDC data on incidence of autism, increase
    • Increase in disease population set to boost the future market
    • Extensive list of facts about autism and the scope of the disorder, by the Autism Society, CDC, NIH, Autism Speaks (economic costs, risk factors and characteristics, etc.)

Tables

  • No. of children with autism by: gender, race, living in a metro area
  • Number of 3-21 Year-Olds With Autism Served Under The Individuals with Disabilities Education Act (IDEA) in the United States: 2000-2021

ABA Treatment Centers & Programs (Applied Behavior Analysis)

  • Summary: Discussion of types of programs: center-based, community, in-home therapy
  • Key metrics (no. of adults and children with autism, avg. revenues per treatment center, avg. per therapist, percent of patients using medications, percent with access to insurance coverage, estimated market value)
  • In-depth description of how ABA programs work, types of therapy, controversies
  • Description of other therapies used (TEAACH, speech therapy, occupational therapy)
  • Discussion of obstacles with insurance coverage, Medicare, Medicaid, other major market issues, insurance coverage is getting better, states without essential health benefit, share of children covered by insurance now vs. 2016.
  • BLS job outlook for Applied Behavior Analysts to 2029, average salaries, shortage
  • Demand for license behavior analysts - annual number of job postings nationwide over the past 12 years (2010-2021)
  • Salary levels for Applied Behavior Analysts: top paying states, hourly/yearly wages
  • Insurance coverage Is getting better: discussion
  • The Cost of Care/ABA programs - Varies by need and type, typical no. of hrs. and cost per year

Chart/Map

  • Insurance coverage for autism treatment, by state: 2016

Market Size & Growth, Market Segments

  • Summary: Discussion of market size estimation methods, known facts about the autism treatment market, major industry metrics
  • Discussion of major drivers of the market

Analysis of Non-profit and For-profit Autism Treatment Centers & Schools:

  • 2020 Market Performance: Effects of the 2020 pandemic, Marketdata estimates of industry $ size and growth, revenue performance of 137 non-profit treatment centers in the Guidestar database (New analysis by Marketdata).
  • 2021 Market Performance: Recovery from the pandemic, shift to partial virtual operations
  • 2022 Market Forecast: Addition of new centers, acquisitions by major for-profit players
  • 2025 Forecast: key factors affecting demand, Marketdata estimates of industry $ size and growth
  • Rationale for estimating market size:
    • by no. of patients in treatment programs
    • by revenues of for-profit and non-profit treatment programs/centers, avg. revenues per center
  • Discussion of available information & proxy indicators
  • Discussion of insurance coverage
  • Growth factors

Analysis of the Autism Medications Market

  • Discussion of reasons for shrinking sales, $ size of the market

Tables

  • List of top 12 treatment chains (no. of centers, estd. revenues, 2018, 2021)
  • Size of the U.S. autism treatment market: 2009-2025 forecast (programs, drugs, total)
  • Size of the autism medications market: 2006-2025 F (Risperdal, Ritalin, Concerta)
  • Incidence of autism, no. of children with autism vs. population: 2000, 2010, 2016, 2020.
  • Estimates of market size and growth by other research firms.

The Market For Autism Medications

  • Summary & Discussion of the drugs currently used to treat behavioral and emotional problems of autistic children, including mood stabilizers, antipsychotics, stimulants

List of drug companies doing research and clinical trials

  • Risperdal: description and uses, side effects and problems
  • Abilify: description and uses, side effects and problems
  • Ritalin: description and uses, side effects and problems
  • Market Size: estimates by Marketdata, actual sales by drug companies, emergence of less costly generics as patents expire
  • New Drugs Under Development (Bumetanide, Balovaptan, Suramin, Lithobid, others)

List of Key Players in the autism drugs market

  • 2022 forecast: Marketdata estimate of $ market size
  • 2025 Forecast: Marketdata estimate of $ market size

Table

  • Estimated sales of autism drugs in the U.S. 2006-2021, 2022 & 2025 Forecasts.

Competitor Profiles (Descriptions of program, number of sites/centers and therapists, specialties, headquarters address, estimated/actual revenues, acquisitions)

  • Autism Treatment Network (Autism Speaks)
  • Autism Learning Partners
  • Autism Spectrum Therapies
  • Butterfly Effects
  • BlueSprig
  • Centria Autism Services
  • The Center for Autism & Related Disorders (CARD)
  • ChanceLight™ Behavioral Health and Education
  • City Pro Group
  • Easter Seals
  • Hi-5 ABA Inc. (franchise)
  • Hopebridge
  • Kadiant
  • LEARN Behavioral
  • The May Institute - (incl. 2018-2021 financial profile/income statement)
  • Success on the Spectrum (franchise)
  • Trumpet Behavioral Health

Reference Directory

  • Directory of autism research, treatment and education organizations, societies,
  • Institutes, magazines, reports, special surveys, experts, other information sources